These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11994292)
1. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. Endo H; Takenaga K; Kanno T; Satoh H; Mori S J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292 [TBL] [Abstract][Full Text] [Related]
2. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943 [TBL] [Abstract][Full Text] [Related]
3. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784 [TBL] [Abstract][Full Text] [Related]
5. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis. Zhou G; Tsai CW; Liu JO J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582 [TBL] [Abstract][Full Text] [Related]
6. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides. Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329 [TBL] [Abstract][Full Text] [Related]
7. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930 [TBL] [Abstract][Full Text] [Related]
8. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases. Wang J; Lou P; Henkin J J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023 [TBL] [Abstract][Full Text] [Related]
11. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity. Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity. Cornelius P; Mayes BA; Petersen JS; Turnquist DJ; Dufour PJ; Dannenberg AJ; Shanahan JM; Carver BJ Mol Cancer Ther; 2024 May; 23(5):595-605. PubMed ID: 38530115 [TBL] [Abstract][Full Text] [Related]
13. Methionine aminopeptidase 2 is required for HSC initiation and proliferation. Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698 [TBL] [Abstract][Full Text] [Related]
14. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target. Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475 [TBL] [Abstract][Full Text] [Related]
15. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers. Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007 [TBL] [Abstract][Full Text] [Related]
17. Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model. Chun E; Han CK; Yoon JH; Sim TB; Kim YK; Lee KY Int J Cancer; 2005 Mar; 114(1):124-30. PubMed ID: 15523682 [TBL] [Abstract][Full Text] [Related]
18. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277 [TBL] [Abstract][Full Text] [Related]
19. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. Lu J; Chong CR; Hu X; Liu JO J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390 [TBL] [Abstract][Full Text] [Related]
20. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]